NEW YORK, NY / ACCESSWIRE / December 11, 2015 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Walter Investment Management Corp. (NYSE: WAC), Foundation Medicine Inc. (NASDAQ: FMI), Aegerion Pharmaceuticals Inc. (NASDAQ: AEGR) and Zogenix Inc. (NASDAQ: ZGNX). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
To access our full PDF Research Packages for free, please visit the links below.
============
Full PDF DOWNLOAD Links
(You may have to copy and paste the links into your browser)
WAC Research Package: http://www.traders-choice.com/pdf?s=WAC
FMI Research Package: http://www.traders-choice.com/pdf?s=FMI
AEGR Research Package: http://www.traders-choice.com/pdf?s=AEGR
ZGNX Research Package: http://www.traders-choice.com/pdf?s=ZGNX
============
Highlights from today's reports include:
On Thursday, December 10, 2015, the NASDAQ Composite ended at 5,045.17, up 0.44%, the Dow Jones Industrial Average advanced 0.47%, to finish the day at 17,574.75, and the S&P 500 closed at 2,052.23, up 0.23%.
- Walter Investment Management Corp's stock increased by 2.44% to close Thursday's session at USD 13.04. The company's shares fluctuated in the range of USD 12.78 and USD 13.40. A total of 0.39 million shares exchanged hands, which surpassed its 50-day daily average volume of 0.31 million shares and its 52-week average volume of 0.29 million shares. Over the last three days Walter Investment Management Corp's shares have advanced 2.52% and in the past one week the stock has moved up 4.49%. However, over the last three months the stock has lost 19.31% and in the past six months the shares have shed 41.76%. Further, the stock is trading at a price to cash flow ratio of 38.93 and price to sales ratio of 29.90. Additionally, the stock is trading at a price to book (MRQ) ratio of 0.5. Moreover, Walter Investment Management Corp is trading below its 50-day moving average of USD 13.52.
- Foundation Medicine Inc.'s stock added 7.79% to close Thursday's session at USD 17.29. The company's shares oscillated between USD 15.58 and USD 17.40, marking a new 52-week low during the session. The stock recorded a trading volume of 0.29 million shares, which was at par with its 50-day daily average volume of 0.29 million shares but below its 52-week average volume of 0.36 million shares. Over the last one week Foundation Medicine Inc.'s shares have advanced 6.33% and in the past one month the stock has gained a momentum of 2.19%. However, over the last three months the stock has lost 26.55% and year to date the shares have shed 22.19%. Further, the stock is trading at a price to book (MRQ) ratio of 2.0 and a price to sales (TTM) ratio of 5.8. Moreover, Foundation Medicine Inc. is trading below its 50-day moving average of USD 18.92.
- Aegerion Pharmaceuticals Inc.'s stock advanced 2.74% to close Thursday's session at USD 9.75. The share price vacillated between USD 9.44 and USD 9.88. The stock recorded a trading volume of 0.52 million shares, which was below its 50-day daily average volume of 0.84 million shares and its 52-week average volume of 0.65 million shares. Over the last three days Aegerion Pharmaceuticals Inc.'s shares have advanced 0.93% but in the past one week the stock has moved down 2.21%. Moreover, in the last six months the stock has lost 49.14% and year to date the shares have shed 53.44%. Further, the stock is trading at a price to book ratio of 1.89 compared to a historical PB ratio of 3.72. Additionally, the stock is trading at a price to cash flow ratio of 14.64 and price to sales ratio of 1.13. Moreover, Aegerion Pharmaceuticals Inc. is trading below its 50-day moving average of USD 12.62.
- Zogenix Inc.'s stock declined 0.44% to close Thursday's session at USD 13.65. The share price vacillated between USD 13.51 and USD 14.03. The stock recorded a trading volume of 0.30 million shares, which was below its 50-day daily average volume of 0.38 million shares and its 52-week average volume of 0.44 million shares. Over the last three days Zogenix Inc.'s shares have declined by 2.78% while in the past one month the stock has moved up 14.61%. Moreover, in the last six months the stock has gained 6.64% and year to date the shares have picked up 24.54%. Further, the stock is trading at a price to earnings ratio of 16.85 compared to historical PE ratio of 23.14. Additionally, the stock is trading at a price to book (MRQ) ratio of 1.8 and price to sales ratio of 9.81. Zogenix Inc. is trading above its 50-day moving average of USD 13.30 but below its 200-day moving average of USD 14.31.
About Trader's Choice:
Trader's Choice ("TC") produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. TC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
TC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer"). The Reviewer has reviewed and revised the content, as necessary, based on sound investment judgment and publicly available information which is believed to be reliable. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer (collectively referred to as the "Production Team") in any way. The Production Team is compensated on a fixed monthly basis and do not hold any positions of interest in any of the securities mentioned herein. The information in this release has been sourced from a third party data base.
NO WARRANTY
TC, the Author and the Reviewer (collectively referred to as the "Publishers") are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.traders-choice.com/.
RESTRICTIONS
TC is not available to residents of Belarus, Cuba, Canada, Iran, North Korea, Sudan, Syria or Somalia.
CONTACT
For any questions, inquiries, or comments reach out to us directly at:
E-mail: press (at) traders-choice.com
SOURCE: Trader's Choice